ClinConnect ClinConnect Logo
Search / Trial NCT05707871

Cardiovascular Effects of Very Low Nicotine Content Cigarettes

Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · Jan 31, 2023

Trial Information

Current as of September 10, 2025

Recruiting

Keywords

Cigarette Smoking Nicotine Content Cardiovascular Disorders

ClinConnect Summary

This clinical trial is studying how very low nicotine content cigarettes affect the heart and blood vessels in both daily and non-daily smokers. Researchers want to understand if smoking these types of cigarettes has different cardiovascular effects compared to regular cigarettes. The study is currently looking for participants aged 21 and older who have smoked at least once in the last month and are willing to smoke either the research cigarettes or their usual brand during a lab visit.

If you decide to join, you'll need to meet certain health criteria. For example, you cannot have a recent diagnosis of heart or blood vessel diseases, and you should not be pregnant or breastfeeding. During the study, you'll be asked to smoke in a controlled setting, and the researchers will monitor your heart health and other measurements. This trial aims to gather important information that could help improve smoking cessation efforts and understand the impacts of different types of cigarettes on cardiovascular health.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Self-reported cigarette smoking at least once in the past 30 days
  • ≥21 years old
  • Willingness to smoke research cigarettes or usual brand cigarettes during lab visit.
  • Ability to speak, comprehend, and read English sufficiently to complete study procedures
  • Exclusion Criteria:
  • Self-reported diagnosis of cardiovascular diseases like coronary artery disease, stroke, peripheral artery disease, cardiac arrhythmia, pulmonary embolism \& blood clots in legs and arm in the past 3 months
  • Body temperature ≥ 100.4˙F
  • Unstable health conditions interfering with electrocardiogram (ECG) measurements
  • Self-reported diagnosis of hyperthyroidism or thyrotoxicosis
  • Currently pregnant (as indicated by urine pregnancy test at the start of laboratory visit) or breastfeeding.
  • Currently seeking treatment to quit smoking

About Wake Forest University Health Sciences

Wake Forest University Health Sciences is a leading academic research institution dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on multidisciplinary collaboration, the organization leverages its extensive expertise in medical research, patient care, and education to develop and evaluate new therapies and interventions. Committed to improving patient outcomes and public health, Wake Forest University Health Sciences fosters a dynamic environment for scientific inquiry, engaging in a wide range of clinical studies that address pressing health challenges. Through its rigorous methodologies and ethical standards, the institution aims to contribute significantly to the medical field and enhance the quality of life for diverse populations.

Locations

Winston Salem, North Carolina, United States

Patients applied

0 patients applied

Trial Officials

Eric C Donny, PhD

Principal Investigator

Wake Forest University Health Sciences

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials